Skip to main content

Medication: Clinical trial

Journal articles and book chapters

05-04-2018 | Dorzagliatin | Article

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: A dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study

Zhu D et al. Lancet Diabetes Endocrinol 2018; Advance online publication. doi: 10.1016/S2213-8587(18)30105-0

05-01-2018 | Glyburide | Article

Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: A randomized clinical trial

Sénat MV et al. JAMA 2018; 319: 1773–1780. doi: 10.1001/jama.2018.4072

04-30-2018 | Insulin degludec | Article

DEVOTE 5: Evaluating the short-term cost-utility of insulin degludec versus insulin glargine U100 in basal–bolus regimens for type 2 diabetes in the UK

Pollock RF et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0430-4

04-26-2018 | Obesity | Review | Article

Intermittent fasting: Is the wait worth the weight?

Stockman MC et al. Curr Obes Rep 2018; Advance online publication. doi: 10.1007/s13679-018-0308-9

04-10-2018 | Sulfonylureas | Article

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: Analyses from the EASYDia trial

Leiter LA, Shestakova MV, Satman I. Diabetol Metab Syndr 2018; 10: 30. doi: 10.1186/s13098-018-0331-8

04-06-2018 | Statins | Article

Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: Report of a randomized study

Itho H et al. Diabetes Care 2018; Advance online publication. doi: 10.2337/dc17-2224

04-04-2018 | Insulin | Article

Basal–bolus insulin therapy with Gla-300 during hospitalization reduces nocturnal hypoglycemia in patients with type 2 diabetes mellitus: A randomized controlled study

Okajima F et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0419-z

03-27-2018 | Nephropathy | Review | Article

New diabetes therapies and diabetic kidney disease progression: The role of SGLT-2 inhibitors

Dekkers CCJ, Gansevoort RT, Heerspink HJL. Curr Diab Rep 2018; 18: 27. doi: 10.1007/s11892-018-0992-6

02-12-2018 | Teneligliptin | Article

Efficacy and safety of teneligliptin 40 mg in type 2 diabetes: A pooled analysis of two phase III clinical studies

Kadowaki T et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0372-x

01-08-2018 | Ertugliflozin | Article

Ertugliflozin and sitagliptin co-initiation in patients with type 2 diabetes: The VERTIS SITA randomized study

Miller S et al. Diabetes Ther 2018; 9: 253–268. doi: 10.1007/s13300-017-0358-0

11-20-2017 | Ertugliflozin | Article

Ertugliflozin in patients with stage 3 chronic kidney disease and type 2 diabetes mellitus: The VERTIS RENAL randomized study

Grunberger G et al. Diabetes Ther 2018; 9: 49–66. doi: 10.1007/s13300-017-0337-5

10-23-2017 | Insulin | Review | Article

Insulin and its cardiovascular effects: What is the current evidence?

Dongerkery SP, Schroeder PR, Shomali ME. Curr Diab Rep 2017; 17: 120. doi: 10.1007/s11892-017-0955-3

10-11-2017 | Cardiovascular disorders | Review | Article

Updates on cardiovascular outcome trials in diabetes

Schnell O et al. Cardiovasc Diabetol 2017; 16: 128. doi: 10.1186/s12933-017-0610-y

09-28-2017 | Type 2 diabetes | Book chapter | Article

Diabetes Prevention Program (DPP) and the Action for Health in Diabetes (Look AHEAD) study: Lessons learned

Gibbs BB, Jakicic JM. In: Diabetes and Exercise. Edited by Reusch JEB et al. Springer International Publishing AG, 2018. doi: 10.1007/978-3-319-61013-9_12

07-19-2017 | Cardiovascular outcomes | Review | Article

Cardiovascular outcome trial update in diabetes: New evidence, remaining qestions

Herbst R et al. Curr Diab Rep 2017; 17: 67. doi: 10.1007/s11892-017-0898-8

06-14-2017 | Hypoglycemia | Article

Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections

Riddlesworth T, Price D, Cohen N, Beck RW. Diabetes Ther 2017; 8: 947–951. doi: 10.1007/s13300-017-0281-4